Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Legislation topic
No spam. Unsubscribe anytime.
Legislative subcommittee reviews bills that could change premium caps and coverage
Summary
Commission’s Legislative Committee reviewed multiple bills (LD 2148, LD 107, LD 582, LD 1502, LD 1530, LD 2119 and others) that could affect premium caps, coverage mandates and later plan costs; fiscal notes ranged from approximately $38K to $57K for two bills affecting the plan.
The Commission’s Legislative Committee summarized several bills that may affect the State Employee Health Plan. LD 2148 would increase the state employee health insurance premium cap to Consumer Price Index plus 10% (status: not reported out yet). LD 107 (biomarker testing coverage) is a carryover with a divided report and an approximated $38,000 fiscal note for the State plan. LD 582 (coverage for blood testing for PFAS) is a carryover with a divided report and an approximate $57,000 fiscal note.
Other bills discussed include LD 1502 (prostate cancer screening coverage updates), LD 1530 (sustainability of emergency medical services), LD 2119 (expand reimbursement for treatment in place and community paramedicine), and multiple bills proposing changes to retiree premiums or state payments for Medicare Part B premiums (LD 111, LD 328, LD 467). LD 2196, discussed March 17, would limit hospital facility price growth starting 2028 and could affect hospital contracting and prior authorization rules if enacted.
The Legislative Committee’s report did not propose immediate Commission action but flagged the bills for monitoring because they could change plan costs or eligibility and therefore influence future premium setting.
